Related Experiment Video
Updated: Apr 3, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Diamine Functionalized Cubic Mesoporous Silica for Ibuprofen Controlled Delivery
Diamine functionalized KIT-6 (N-KIT-6) enhances ibuprofen adsorption and release for controlled drug delivery. This modified mesoporous silica shows improved performance over standard KIT-6 due to its hydrophobic nature and basic sites.
Area of Science:
- Materials Science
- Nanotechnology
- Drug Delivery
Background:
- Mesoporous silica materials like KIT-6 are promising for drug delivery applications.
- Functionalization of mesoporous silica can enhance its adsorption and release properties.
Purpose of the Study:
- To synthesize and characterize diamine functionalized KIT-6 (N-KIT-6) mesoporous silica.
- To evaluate the potential of N-KIT-6 for controlled drug delivery using ibuprofen (IBU) as a model drug.
Main Methods:
- Post-synthetic functionalization of calcined KIT-6 with N-[3-(trimethoxysilyl)-propyl]ethylenediamine.
- Characterization using Small-Angle X-ray Scattering (SAXS), N2 sorption, FT-IR, SEM, TEM, and TGA.
- Monitoring ibuprofen adsorption and release rates using UV-Vis spectrophotometry.
Main Results:
- Successful synthesis of N-KIT-6 with confirmed diamine groups and preserved mesoporous structure.
- N-KIT-6 exhibited higher ibuprofen adsorption and release rates compared to unmodified KIT-6.
- Enhanced performance attributed to N-KIT-6's increased hydrophobicity and abundant surface basic sites.
Conclusions:
- Diamine functionalization is an effective strategy to improve the drug delivery capabilities of KIT-6.
- N-KIT-6 demonstrates significant potential as a carrier for controlled drug release systems.
- The modified material offers advantages for enhanced drug loading and release kinetics.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed I
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Modified-Release Drug Delivery Systems: Classification

